Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Gieffers

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|November 24, 2007
Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and DJan Rupp, Werner Solbach, Jens Gieffers
GMS Hygiene and Infection Control|October 26, 2016
Long term observation of MRSA prevalence in a German rehabilitation center: risk factors and variability of colonization rateJens Gieffers, André Ahuja, Ronald Giemulla
FEMS Microbiology Letters|June 15, 2007
Prevalence, genetic conservation and transmissibility of the Chlamydia pneumoniae bacteriophage (phiCpn1)Jan Rupp, Werner Solbach, Jens Gieffers
Applied and Environmental Microbiology|May 5, 2006
Single-nucleotide-polymorphism-specific PCR for quantification and discrimination of Chlamydia pneumoniae genotypes by use of a "locked" nucleic acidJan Rupp, Werner Solbach, Jens Gieffers
Journal of Clinical Microbiology|June 8, 2006
Be aware of the possibility of false-positive results in single-locus PCR assays for methicillin-resistant Staphylococcus aureusJan Rupp, Ines Fenner, Werner Solbach, et al.
Antimicrobial Agents and Chemotherapy|February 16, 2011
Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatisKensuke Shima, Márta Szaszák, Werner Solbach, et al.
Developmental Medicine and Child Neurology|August 15, 2006
Recurrent optic neuritis associated with Chlamydia pneumoniae infection of the central nervous systemDaniela Pohl, Kevin Rostasy, Jens Gieffers, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniaeJens Gieffers, Jan Rupp, Andreas Gebert, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Growth cycle-dependent pharmacodynamics of antichlamydial drugsKatrin Siewert, Jan Rupp, Matthias Klinger, et al.
Cellular Microbiology|January 7, 2004
Chlamydia pneumoniae and atherosclerosisRobert J Belland, Scot P Ouellette, Jens Gieffers, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|November 24, 2007
Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and DJan Rupp, Werner Solbach, Jens Gieffers
GMS Hygiene and Infection Control|October 26, 2016
Long term observation of MRSA prevalence in a German rehabilitation center: risk factors and variability of colonization rateJens Gieffers, André Ahuja, Ronald Giemulla
FEMS Microbiology Letters|June 15, 2007
Prevalence, genetic conservation and transmissibility of the Chlamydia pneumoniae bacteriophage (phiCpn1)Jan Rupp, Werner Solbach, Jens Gieffers
Applied and Environmental Microbiology|May 5, 2006
Single-nucleotide-polymorphism-specific PCR for quantification and discrimination of Chlamydia pneumoniae genotypes by use of a "locked" nucleic acidJan Rupp, Werner Solbach, Jens Gieffers
Journal of Clinical Microbiology|June 8, 2006
Be aware of the possibility of false-positive results in single-locus PCR assays for methicillin-resistant Staphylococcus aureusJan Rupp, Ines Fenner, Werner Solbach, et al.
Antimicrobial Agents and Chemotherapy|February 16, 2011
Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatisKensuke Shima, Márta Szaszák, Werner Solbach, et al.
Developmental Medicine and Child Neurology|August 15, 2006
Recurrent optic neuritis associated with Chlamydia pneumoniae infection of the central nervous systemDaniela Pohl, Kevin Rostasy, Jens Gieffers, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniaeJens Gieffers, Jan Rupp, Andreas Gebert, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Growth cycle-dependent pharmacodynamics of antichlamydial drugsKatrin Siewert, Jan Rupp, Matthias Klinger, et al.
Cellular Microbiology|January 7, 2004
Chlamydia pneumoniae and atherosclerosisRobert J Belland, Scot P Ouellette, Jens Gieffers, et al.
Pageof 2